DMRA
Damora Therapeutics, Inc.stockNASDAQ
Market OpenNov 19, 2026 9:38:50 AM EST
23.12USD+0.675%(+0.16)5,776
DMRA Financials
In Q3 FY 2026 (ended ), Damora Therapeutics, Inc. (DMRA) reported net income of −$31.99M, operating cash flow of −$17.23M, and assets of $532.63M (filed ).
Loading financial flows…